Reverse Merger and Contingent Value Rights - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	12 Months Ended
	Oct. 05, 2020	Aug. 31, 2020	Dec. 31, 2021
Business Acquisition [Line Items]
Fair value of acquired renal in process research and development intangible asset	$ 32.4
Fair value of acquired intangible asset	26.7
Contingent consideration liabilities for related contingent value rights	$ 8.1
Combined transaction costs			$ 4.5
Private Chinook
Business Acquisition [Line Items]
Percentage of voting interests acquired	100.00%
Shares of common stock issued	16,300,000
Merger agreement date	Jun. 01, 2020
Common stock exchange ratio	0.292188
Exchange ratio, description			effective time of the Merger, we issued shares of our common stock to Private Chinook stockholders, at an exchange rate of 0.292188 shares of Aduro common stock for each share of Private Chinook common stock outstanding immediately prior to the Merger, including shares sold in the Pre-Closing Financing and all shares of Series A redeemable convertible preferred stock which converted into Private Chinook’s shares of common stock on a one-for-one basis prior to closing of the Merger (the “Exchange Ratio”). We also assumed all the stock options outstanding under the Private Chinook 2019 Equity Incentive Plan. Unless otherwise noted herein, references to our common share and per-share amounts give retroactive effect to the Exchange Ratio.
Value of common stock agreed to purchase by investors		$ 115.0
Number of common stock purchased by investors	9,600,000
Common stock price	$ 12.00